View in EDS

Active surveillance selection and 3-year durability in intermediate-risk prostate cancer following genomic testing.

Saved in:
Bibliographic Details
Title: Active surveillance selection and 3-year durability in intermediate-risk prostate cancer following genomic testing.
Authors: Lenz L; Myriad Genetics, Inc., Salt Lake City, UT, USA., Clegg W; Myriad Genetics, Inc., Salt Lake City, UT, USA., Iliev D; Myriad Genetics, Inc., Salt Lake City, UT, USA., Kasten CR; Myriad Genetics, Inc., Salt Lake City, UT, USA., Korman H; Comprehensive Urology, Royal Oak, MI, USA.; Wayne State University, Detroit, MI, USA., Morgan TM; University of Michigan, Ann Arbor, MI, USA., Hafron J; Michigan Institute of Urology, Troy, MI, USA., DeHaan A; Urologic Consultants, Wyoming, MI, USA., Olsson C; Integrated Medical Professionals, Melville, NY, USA., Tutrone RF Jr; Chesapeake Urology, Towson, MD, USA., Richardson T; Wichita Urology, Pratt, KS, USA., Cline K; Regional Urology, Shreveport, LA, USA., Yonover PM; UroPartners, Chicago, IL, USA., Jasper J; Myriad Genetics, Inc., Salt Lake City, UT, USA., Cohen T; Myriad Genetics, Inc., Salt Lake City, UT, USA., Finch R; Myriad Genetics, Inc., Salt Lake City, UT, USA., Slavin TP Jr; Myriad Genetics, Inc., Salt Lake City, UT, USA., Gutin A; Myriad Genetics, Inc., Salt Lake City, UT, USA. agutin@myriad.com.
Source: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2025 Jun; Vol. 28 (2), pp. 427-434. Date of Electronic Publication: 2024 Sep 05.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9815755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5608 (Electronic) Linking ISSN: 13657852 NLM ISO Abbreviation: Prostate Cancer Prostatic Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39237680
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Active surveillance selection and 3-year durability in intermediate-risk prostate cancer following genomic testing.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lenz+L%22">Lenz L</searchLink>; Myriad Genetics, Inc., Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Clegg+W%22">Clegg W</searchLink>; Myriad Genetics, Inc., Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Iliev+D%22">Iliev D</searchLink>; Myriad Genetics, Inc., Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Kasten+CR%22">Kasten CR</searchLink>; Myriad Genetics, Inc., Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Korman+H%22">Korman H</searchLink>; Comprehensive Urology, Royal Oak, MI, USA.; Wayne State University, Detroit, MI, USA.<br /><searchLink fieldCode="AU" term="%22Morgan+TM%22">Morgan TM</searchLink>; University of Michigan, Ann Arbor, MI, USA.<br /><searchLink fieldCode="AU" term="%22Hafron+J%22">Hafron J</searchLink>; Michigan Institute of Urology, Troy, MI, USA.<br /><searchLink fieldCode="AU" term="%22DeHaan+A%22">DeHaan A</searchLink>; Urologic Consultants, Wyoming, MI, USA.<br /><searchLink fieldCode="AU" term="%22Olsson+C%22">Olsson C</searchLink>; Integrated Medical Professionals, Melville, NY, USA.<br /><searchLink fieldCode="AU" term="%22Tutrone+RF+Jr%22">Tutrone RF Jr</searchLink>; Chesapeake Urology, Towson, MD, USA.<br /><searchLink fieldCode="AU" term="%22Richardson+T%22">Richardson T</searchLink>; Wichita Urology, Pratt, KS, USA.<br /><searchLink fieldCode="AU" term="%22Cline+K%22">Cline K</searchLink>; Regional Urology, Shreveport, LA, USA.<br /><searchLink fieldCode="AU" term="%22Yonover+PM%22">Yonover PM</searchLink>; UroPartners, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Jasper+J%22">Jasper J</searchLink>; Myriad Genetics, Inc., Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Cohen+T%22">Cohen T</searchLink>; Myriad Genetics, Inc., Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Finch+R%22">Finch R</searchLink>; Myriad Genetics, Inc., Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Slavin+TP+Jr%22">Slavin TP Jr</searchLink>; Myriad Genetics, Inc., Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Gutin+A%22">Gutin A</searchLink>; Myriad Genetics, Inc., Salt Lake City, UT, USA. agutin@myriad.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229815755%22">Prostate cancer and prostatic diseases</searchLink> [Prostate Cancer Prostatic Dis] 2025 Jun; Vol. 28 (2), pp. 427-434. <i>Date of Electronic Publication: </i>2024 Sep 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Observational Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9815755 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5608 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213657852%22">13657852 </searchLink><i>NLM ISO Abbreviation: </i>Prostate Cancer Prostatic Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39237680
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41391-024-00888-y
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 427
    Titles:
      – TitleFull: Active surveillance selection and 3-year durability in intermediate-risk prostate cancer following genomic testing.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lenz L
      – PersonEntity:
          Name:
            NameFull: Clegg W
      – PersonEntity:
          Name:
            NameFull: Iliev D
      – PersonEntity:
          Name:
            NameFull: Kasten CR
      – PersonEntity:
          Name:
            NameFull: Korman H
      – PersonEntity:
          Name:
            NameFull: Morgan TM
      – PersonEntity:
          Name:
            NameFull: Hafron J
      – PersonEntity:
          Name:
            NameFull: DeHaan A
      – PersonEntity:
          Name:
            NameFull: Olsson C
      – PersonEntity:
          Name:
            NameFull: Tutrone RF Jr
      – PersonEntity:
          Name:
            NameFull: Richardson T
      – PersonEntity:
          Name:
            NameFull: Cline K
      – PersonEntity:
          Name:
            NameFull: Yonover PM
      – PersonEntity:
          Name:
            NameFull: Jasper J
      – PersonEntity:
          Name:
            NameFull: Cohen T
      – PersonEntity:
          Name:
            NameFull: Finch R
      – PersonEntity:
          Name:
            NameFull: Slavin TP Jr
      – PersonEntity:
          Name:
            NameFull: Gutin A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2025 Jun
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1476-5608
          Numbering:
            – Type: volume
              Value: 28
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Prostate cancer and prostatic diseases
              Type: main
ResultId 1